News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PAKOLA STEVE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2022 |
4
| PAKOLA STEVE (Chief Medical Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 1,152 shares
@ $32.7, valued at
$37.7k
Sold 1,598 shares
@ $33.75, valued at
$53.9k
Granted 8,900 shares
@ $0
Granted 42,500 options to buy
@ $34.31, valued at
$1.5M
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2019 |
4
| PAKOLA STEVE (Chief Medical Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 95,000 options to buy
@ $54.72, valued at
$5.2M
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2018 |
4
| PAKOLA STEVE (Chief Medical Officer) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.59, valued at
$359k
|
|
|
|